-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Intellipharmaceutics International Inc. annual/quarterly Interest Expense history and growth rate from Q1 2016 to Q2 2017.
- Intellipharmaceutics International Inc. Interest Expense for the quarter ending May 31, 2017 was CA$103K, a 75.8% increase year-over-year.
- Intellipharmaceutics International Inc. annual Interest Expense for 2018 was CA$255K, a 34.4% decline from 2017.
- Intellipharmaceutics International Inc. annual Interest Expense for 2017 was CA$389K, a 44% increase from 2016.
- Intellipharmaceutics International Inc. annual Interest Expense for 2016 was CA$270K, a 5.3% increase from 2015.
Interest Expense, Quarterly (CAD)
Interest Expense, YoY Quarterly Growth (%)